Latest News
CyberArk Software Inc. (NASDAQ: CYBR) shares are trading higher Tuesday after a report from The Wall Street Journal revealed that Palo Alto Networks is in talks to acquire the company for more than $20 billion.
Via Benzinga · July 29, 2025
Via Benzinga · July 29, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · July 29, 2025
The Canadian Dollar backslid further on Tuesday as the Greenback continues to rise.
Via Talk Markets · July 29, 2025
Shares of Super Micro Computer are trading marginally lower Tuesday. The market is anticipating the company's Q4 earnings report.
Via Benzinga · July 29, 2025
Since 1995, the rebound in speculative measures over the past three months has been one of the sharpest on record, and in rare company with now infamous bubble tops in 1999-2000 and 2021.
Via Talk Markets · July 29, 2025
JPMorgan upgraded Sarepta to ‘Neutral’ from ‘Underweight’ with a $24 price target.
Via Stocktwits · July 29, 2025
QuantumScape Corporation (NYSE:QS), a leading developer of solid-state lithium-metal batteries for electric vehicles, saw its shares drop sharply following its latest earnings announcement. The decline reflects growing investor concern over the company’s financial performance, delayed commercialization roadmap, and heightened competition in the solid-state battery space.
Post-Earnings Stock Reaction
Via MarketMinute · July 29, 2025
Nvidia CEO Jensen Huang once celebrated a company milestone with a tattoo. Investors who bought the stock after the tattoo image surfaced have been pleasantly rewarded.
Via Benzinga · July 29, 2025
In a surprising twist that blends the emerging world of cryptocurrencies with traditional tech equities, Hyperscale Data Inc. (NASDAQ:HYPR) has seen a notable surge in its stock value following the revelation of significant XRP token accumulation on its balance sheet. The unconventional move has triggered strong interest from retail
Via MarketMinute · July 29, 2025
Teva anticipates EBITDA recovery post-2025 as Austedo and Uzedy grow and generic Revlimid faces rising competition.
Via Benzinga · July 29, 2025
Shares of waste management services provider Waste Management (NYSE:WM)
jumped 3.3% in the afternoon session after the company reported strong second-quarter results that surpassed analyst expectations for both revenue and profit. The company posted revenue of $6.43 billion, marking a 19% increase year-over-year, alongside an adjusted earnings per share of $1.92. This growth was largely fueled by the acquisition of Stericycle, which contributed significantly to the positive results. In addition to beating on the top and bottom lines, Waste Management achieved a record operating expense margin, highlighting operational efficiency. The company also boosted investor confidence by raising its full-year free cash flow guidance by $125 million, projecting a range between $2.8 billion and $2.9 billion.
Via StockStory · July 29, 2025
Shares of offshore banking group Butterfield Bank (NYSE:NTB) jumped 3.8% in the afternoon session after the company reported strong second-quarter financial results that beat analyst expectations and announced an increase in its shareholder returns. The bank posted earnings per share of $1.26, surpassing consensus estimates, on revenue of $146.40 million, which marked a 2.31% increase year-over-year. Alongside the positive earnings, Butterfield announced a 14% increase to its quarterly dividend, bringing it to $0.50 per share, and initiated a new share repurchase program. This enhanced capital return strategy, coupled with the strong quarterly performance, underscored management's confidence and commitment to delivering shareholder value. The reported earnings also represented a notable improvement compared to the $1.09 per share earned in the same quarter of the prior year.
Via StockStory · July 29, 2025
Shares of home appliances manufacturer Whirlpool (NYSE:WHR)
fell 12.6% in the afternoon session after the company reported disappointing second-quarter earnings, significantly cut its dividend, and lowered its full-year financial forecast. The company's second-quarter earnings per share of $1.34 missed analyst expectations, and net sales fell 5.4% year-over-year to $3.77 billion. Management pointed to declining global demand, increased promotions, and competitors stockpiling imports ahead of U.S. tariffs as key pressures on the results. In response to the challenging environment, Whirlpool reduced its full-year earnings guidance to a range of $6.00 to $8.00 per share, a significant drop from its previous forecast of around $10.00. The company also announced a major cut to its annual dividend, lowering it to $3.60 per share. Following the news, Bank of America downgraded the stock to "underperform" and reduced its price target to $70.
Via StockStory · July 29, 2025
Shares of semiconductor design software provider Cadence Design Systems (NASDAQ:CDNS) jumped 9.1% in the afternoon session after the company reported strong second-quarter results that surpassed analyst expectations and raised its full-year financial outlook. The electronic design automation (EDA) company, which provides software and hardware for designing semiconductors, posted second-quarter adjusted earnings of $1.65 per share on revenue of $1.28 billion. This revenue figure represented a 20% increase year-over-year, and both metrics beat analyst forecasts. The strong performance was attributed to high demand from the artificial intelligence, high-performance computing, and automotive sectors. This result came despite Cadence disclosing a one-time charge of $140.6 million to settle legal proceedings with the U.S. government over its business operations in China. Investors appeared to focus on the strong results, as the company also increased its 2025 revenue forecast to a range of $5.21 billion to $5.27 billion and its adjusted EPS guidance to between $6.85 and $6.95. Following the news, analysts at firms including J.P. Morgan and Wells Fargo raised their price targets.
Via StockStory · July 29, 2025
Shares of diversified bank holding company Merchants Bancorp (NASDAQCM:MBIN) fell 8.9% in the afternoon session after the company reported disappointing second-quarter 2025 earnings that fell significantly short of analyst expectations. The bank posted diluted earnings per share of $0.60, missing the consensus analyst estimate of $1.12. Net income for the quarter came in at $38.0 million, a significant drop from the $76.4 million earned in the same period a year earlier. The company attributed the decline primarily to a large increase in its provision for credit losses. This provision was linked to lower appraised values on multi-family properties and an ongoing investigation into borrower mortgage fraud. In response to the results, analysts at Raymond James lowered their price target on the stock, highlighting the earnings miss and increased net charge-offs.
Via StockStory · July 29, 2025
Shares of equipment rental company Herc Holdings (NYSE:HRI) fell 17.9% in the afternoon session after the company issued a disappointing full-year forecast that overshadowed its second-quarter financial results. While the equipment rental company's revenue grew 18.2% year-over-year to $1.00 billion, it reported a net loss of $35 million. This loss stemmed primarily from $73 million in costs related to its acquisition of H&E Equipment Services and a $49 million asset impairment. The market reacted negatively to the company's updated guidance for the full year, with its revenue projection falling 15% below analyst expectations. The acquisition also increased Herc's debt load and pushed its net leverage ratio to 3.8x, amplifying concerns about the company's financial stability amid the costly integration process.
Via StockStory · July 29, 2025
Shares of global pharmaceutical company Merck (NYSE:MRK)
fell 3.2% in the afternoon session after the company reported second-quarter financial results that missed revenue expectations and revealed a new multi-year cost-cutting initiative. The pharmaceutical giant posted total sales of $15.8 billion, representing a 2% decrease from the same period last year. This revenue shortfall was primarily driven by a steep 55% drop in sales for its Gardasil vaccine, which faced declining demand in China. While the company's earnings per share beat analysts' forecasts, investors appeared to focus on the top-line miss. Alongside the earnings, Merck announced a major restructuring plan aimed at saving $3 billion annually through measures that included layoffs and real estate reductions. The company stated these savings would be reinvested to support new product launches and its research pipeline.
Via StockStory · July 29, 2025
Shares of manufacturing company Stanley Black & Decker (NYSE:SWK)
fell 7.8% in the afternoon session after the company reported second-quarter results that beat profit forecasts but fell short on revenue, raising investor concerns about sales and profitability. The toolmaker posted adjusted earnings of $1.08 per share, which beat Wall Street forecasts. However, revenues of approximately $3.95 billion missed consensus estimates and represented a 2% decline from the prior year. The company attributed the sales drop to a sluggish outdoor buying season and disruptions related to tariffs. Compounding the concerns, the company's gross margin also declined year-over-year, signaling pressure on its profitability. The combination of a revenue shortfall and shrinking margins overshadowed the earnings beat, leading investors to sell off the stock.
Via StockStory · July 29, 2025
Shares of biopharmaceutical company Incyte Corporation (NASDAQ:INCY)
jumped 10.4% in the afternoon session after the company reported second-quarter financial results that beat analyst expectations and raised its full-year guidance for its top-selling drug, Jakafi. The specialty drugmaker posted quarterly revenue of $1.22 billion, a significant 17.3% increase from the previous year, which surpassed the consensus estimate of $1.15 billion. Its adjusted profit of $1.57 per share also came in ahead of Wall Street's forecasts. The strong performance was driven by robust product sales, with revenue from its flagship drug Jakafi growing by 8% and sales of its Opzelura cream surging 35% year-over-year. Citing continued demand, Incyte lifted its 2025 sales forecast for Jakafi to a new range of $3.0 billion to $3.05 billion.
Via StockStory · July 29, 2025
Shares of aerospace and defense company Boeing (NYSE:BA)
fell 3.8% in the afternoon session as investors focused on production delays and potential labor disputes despite reporting better-than-expected second-quarter revenue and a smaller loss. The company posted quarterly revenue of $22.7 billion and a core loss per share of $1.24, both beating analyst forecasts. However, positive sentiment was tempered by significant headwinds. Boeing announced that the certification for its new 777-9 and 737 MAX 7 and 10 models was delayed until 2026, a notable setback.
Via StockStory · July 29, 2025
Shares of electrical and electronic products company Hubbell (NYSE:HUBB)
fell 3.2% in the afternoon session after the company reported mixed second-quarter financial results, where a miss on revenue overshadowed a strong earnings beat. The electrical products manufacturer posted revenue of $1.48 billion, which fell short of analysts' consensus estimates of $1.51 billion. This top-line miss appeared to concern investors more than the company's otherwise strong bottom-line performance. Hubbell reported adjusted earnings of $4.93 per share, significantly surpassing Wall Street expectations. Furthermore, the company raised its full-year earnings guidance to a range of $17.65 to $18.15 per share. Despite the positive earnings and improved outlook, the market's reaction suggested that the slowdown in sales growth weighed heavily on sentiment.
Via StockStory · July 29, 2025
Novo Nordisk A/S (NYSE:NVO) has evolved over the past century from a humble insulin manufacturer in Denmark into one of the world’s most valuable pharmaceutical companies. With a commanding presence in diabetes care and a rapidly expanding footprint in obesity, rare disease, and cardiovascular treatments, the company's
Via MarketMinute · July 29, 2025
Shares of glass and electronic component manufacturer Corning (NYSE:GLW) jumped 12.7% in the afternoon session after the company reported stellar second-quarter financial results that surpassed analyst expectations, driven by surging demand for its AI-related products. The materials science company announced that core sales grew 12% year-over-year to $4.05 billion, while core earnings per share (EPS) jumped 28% to $0.60, beating analyst estimates. This performance was largely attributed to the Optical Communications division, where enterprise sales soared by an impressive 81% year-over-year, propelled by strong demand for products used in Generative AI. Bolstering investor confidence, the company also issued an optimistic forecast for the third quarter, projecting core sales of around $4.2 billion and signaling that management expected the positive momentum to persist.
Via StockStory · July 29, 2025
Shares of heating, ventilation, air conditioning, and refrigeration company Carrier Global (NYSE:CARR)
fell 11.4% in the afternoon session after the company reported mixed second-quarter financial results and lowered its full-year sales guidance for its residential segment. Although the air conditioner maker beat analysts' estimates for second-quarter profit with a 26% year-over-year increase in adjusted earnings per share to $0.92, its revenue of $6.11 billion fell short of consensus estimates. Investor concern appeared to center on the company's outlook. Carrier lowered its full-year forecast for residential organic sales growth, citing a late start to the summer which led to a fall in orders. The market's negative reaction suggested that the revenue miss and reduced guidance for a key segment outweighed the strong profit performance.
Via StockStory · July 29, 2025
Shares of parcel delivery company UPS (NYSE:UPS)
fell 8.8% in the afternoon session after the company reported second-quarter results that missed profit expectations and refrained from providing a full-year financial outlook, citing economic uncertainty. The shipping giant posted an adjusted earnings per share of $1.55, just shy of the $1.57 analysts had predicted. While revenue of $21.2 billion was slightly ahead of forecasts, it represented a nearly 3% decline from the previous year. The company's decision to not issue new full-year guidance appeared to be a significant driver of the stock's decline, as management pointed to "macro-economic uncertainty." Adding to the concerns, UPS’s U.S. domestic operating margin of 7% came in below the forecast of 7.3%, signaling pressure on profitability.
Via StockStory · July 29, 2025
Palo Alto Networks is reportedly on the verge of a major acquisition -- and its stock is falling in response to the news.
Via The Motley Fool · July 29, 2025
After months of underperformance, value stocks—especially in the small-cap space—are staging a quiet comeback.
Via Talk Markets · July 29, 2025
Brokerage Stifel raised its price target on Hershey to $180 from $160 and maintained a ‘Hold’ rating as it approached the second-quarter earnings season "with caution."
Via Stocktwits · July 29, 2025
Chalamet will headline Lucid’s new marketing campaign for its Gravity SUV later this year.
Via Stocktwits · July 29, 2025
Barclays PLC, one of the most influential financial institutions in the world today, traces its origins back over three centuries to the coffee houses and counting houses of London. From its modest beginnings as a Quaker-led partnership to becoming a pillar of international banking, Barclays has evolved through mergers, innovations,
Via MarketMinute · July 29, 2025
In a surprising turn of events, shares of pharmaceutical giant Novo Nordisk (NYSE:NVO) fell sharply following the company’s announcement of a significant leadership restructuring. The abrupt changes at the top echelons of the Danish drugmaker sent shockwaves through the investor community, wiping billions off its market capitalization and
Via MarketMinute · July 29, 2025
The woes continue for this troubled insurance giant.
Via The Motley Fool · July 29, 2025
Koninklijke Philips N.V. (AMS:PHIA), commonly known as Philips, is one of the most storied companies in the history of European industry. Founded in 1891 in Eindhoven, Netherlands, Philips has evolved from a modest light bulb manufacturer into a global leader in health technology and medical innovation. Its transformation
Via MarketMinute · July 29, 2025
The sheer diversity of the Asia-Pacific fixed income market presents both a challenge and an opportunity.
Via Talk Markets · July 29, 2025
The Ozempic maker's stock is dropping fast -- here's why.
Via The Motley Fool · July 29, 2025
Amazon (AMZN - Free Report) stock has seen a sharp rebound in the last three months, surging more than +20% to help lead the unprecedented recovery among the broader indexes.
Via Talk Markets · July 29, 2025
Universal Health Services beat Q2 earnings and raised full-year guidance, but growth concerns in behavioral health weighed on the core performance.
Via Benzinga · July 29, 2025
In a sharp turn that caught markets by surprise, shares of Barclays PLC (LSE:BARC) surged on Tuesday following the release of its latest earnings report, which revealed a significantly higher-than-expected profit. The British banking giant posted robust quarterly results driven by a surge in fixed-income trading, lower-than-forecast credit losses,
Via MarketMinute · July 29, 2025
Lucid could be splitting its stock soon -- but in reverse. Why?
Via The Motley Fool · July 29, 2025